Libella Gene Therapeutics' mission is to reverse aging and cure all age-related diseases. Libella has exclusively licensed the AAV Telomerase gene (hTERT) therapy technology from Sierra Sciences, LLC.
View Top Employees from Libella Gene Therapeutics| Website | http://www.libellagenetherapeutics.com |
| Revenue | $202000 |
| Employees | View employees |
| Address | 2021 Vanesta Pl Ste D, Manhattan, Kansas 66503, US |
| Phone | (785) 320-6616 |
| Industry | Business Services General, Therapeutics, Business Services, Health Care |
| Competitors | AgeX Therapeutics, Inc., Alkahest, Inc., American Gene Technologies® International Inc., Brainstorm Cell Therapeutics, Seelos Therapeutics, Inc. |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular Libella Gene Therapeutics employee's phone or email?
Libella Gene Therapeutics Questions
The Libella Gene Therapeutics annual revenue was $202000 in 2023.
Libella Gene Therapeutics is based in Manhattan, Kansas.
The NAICS codes for Libella Gene Therapeutics are [541, 54171, 5417, 54, 541714].
The SIC codes for Libella Gene Therapeutics are [873, 87].
Related Companies
